Highlights Newsletter 2
This newsletter presents you the following key sessions:
5. Impact of FGFR2-rearrangements in treatment response to systemic therapies in cholangiocarcinoma
This newsletter presents you the following key sessions:
5. Impact of FGFR2-rearrangements in treatment response to systemic therapies in cholangiocarcinoma
Medical writer
Medical writer